March 7 2023
https://pubmed.ncbi.nlm.nih.gov/36879183/
Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection
Excerpt
The meta-analysis of three trials involving 382 patients revealed that the mean time to viral clearance was 5.74 days shorter in case of ivermectin treatment compared to the control groups [WMD = -5.74, 95% CI (-11.1, -0.39), p = 0.036].
Ivermectin has significantly reduced the time to viral clearance in mild to moderate COVID-19 diseases compared to control groups.
However, more eligible studies are needed for analysis to increase the quality of evidence of ivermectin use in COVID-19.
- Forums
- Breaking News
- COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED
COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-86400
-
- There are more pages in this discussion • 12,632 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online